Lexeo Therapeutics Inc (LXEO)

SG&A Expenses

$8.99M

Quarterly · Period ending: · USD

LXEO logo

LXEO SG&A Expenses

Latest reported$8.99M
LXEO Quarterly SG&A Expenses ($2.45M → $8.99M)
High-resolution chart · PNG

LXEO sg&a expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lexeo Therapeutics Inc SG&A Expenses — Quarterly (USD)
Period endingSG&A Expenses (USD)
8,993,000
6,630,000
6,906,000
5,953,000
15,967,000
16,634,000
9,016,000
8,120,000
6,990,000
7,549,000
6,764,000
3,027,000
2,739,000
2,852,000
3,810,000
2,651,000
3,081,000
2,451,736
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.